Ri, M., Suzuki, K., Iida, S., Hatake, K., Chou, T., Taniwaki, M., . . . Tsukamoto, T. (2017). A Phase I/II Study for Dose-finding, and to Investigate the Safety, Pharmacokinetics and Preliminary Efficacy of NK012, an SN-38-Incorporating Macromolecular Polymeric Micelle, in Patients with Multiple Myeloma. Intern Med.
Chicago Style CitationRi, Masaki, Kenshi Suzuki, Shinsuke Iida, Kiyohiko Hatake, Takaaki Chou, Masafumi Taniwaki, Noriko Watanabe, i Tetsuji Tsukamoto. "A Phase I/II Study for Dose-finding, and to Investigate the Safety, Pharmacokinetics and Preliminary Efficacy of NK012, an SN-38-Incorporating Macromolecular Polymeric Micelle, in Patients With Multiple Myeloma." Intern Med 2017.
Cita MLARi, Masaki, et al. "A Phase I/II Study for Dose-finding, and to Investigate the Safety, Pharmacokinetics and Preliminary Efficacy of NK012, an SN-38-Incorporating Macromolecular Polymeric Micelle, in Patients With Multiple Myeloma." Intern Med 2017.